Sudarshan Pharma Industries Ltd — Others, 17-07-2025: AGM/EGM

Sudarshan Pharma Industries has announced an Extraordinary General Meeting (EGM) on August 11, 2025, to seek shareholder approval for raising capital up to INR 1500 Crore. The company plans to issue various securities, including equity shares, Global Depository Receipts (GDRs), or Foreign Currency Convertible Bonds (FCCBs), through public, private, or institutional placements. The funds raised will be utilized for growth, expansion, capital expenditure, working capital needs, and strategic investments in India and overseas. This move aims to strengthen the company's financial position for future business opportunities.